[HTML][HTML] Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential
L Gao, Y Zhang, K Sterling, W Song - Translational Neurodegeneration, 2022 - Springer
Synaptic abnormalities are a cardinal feature of Alzheimer’s disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …
arise as the disease progresses. A growing body of evidence suggests that pathological …
[HTML][HTML] Amyloid β-based therapy for Alzheimer's disease: Challenges, successes and future
Y Zhang, H Chen, R Li, K Sterling… - Signal transduction and …, 2023 - nature.com
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer’s disease (AD),
and its accumulation has been considered as the molecular driver of Alzheimer’s …
and its accumulation has been considered as the molecular driver of Alzheimer’s …
Raised serum levels of tumour necrosis factor in parasitic infections
P Scuderi, KS Lam, KJ Ryan, E Petersen, KE Sterling… - The Lancet, 1986 - Elsevier
In a study of serum levels of endogenous tumour necrosis factor (TNF) in healthy people
and patients with neoplastic or infectious disease, only patients with kala-azar (visceral …
and patients with neoplastic or infectious disease, only patients with kala-azar (visceral …
A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism …
…, MR Jaff, K Ouriel, TC Engelhardt, KM Sterling… - Cardiovascular …, 2015 - jacc.org
Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using the …
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using the …
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects
…, SH Ingbar, K Sterling - The Journal of clinical …, 1970 - Am Soc Clin Investig
… Analyses for the concentration of stable T3 in serum were carried out by the method of
Sterling, … Sterling, K. 1958. Radiothyroxine turnover studies in thyroid disease after therapy. …
Sterling, … Sterling, K. 1958. Radiothyroxine turnover studies in thyroid disease after therapy. …
The immunoregulatory function of vitamin D: implications in chronic kidney disease
KA Sterling, P Eftekhari, M Girndt, PL Kimmel… - Nature Reviews …, 2012 - nature.com
Cardiovascular and infectious diseases remain the most common causes of death among
patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Basic …
patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Basic …
A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial
VF Tapson, K Sterling, N Jones, M Elder… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives : The aim of this study was to determine the lowest optimal tissue plasminogen
activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed …
activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed …
[PDF][PDF] The tagging of red cells and plasma proteins with radioactive chromium
SJ Gray, K Sterling - The Journal of Clinical Investigation, 1950 - Am Soc Clin Investig
… It disintegrates by K capture with transmutation to vanadium and emission of Xrays of 4.92
… M., and Sterling, K., The colorimetric determination of trace amounts of chromium in tissues. …
… M., and Sterling, K., The colorimetric determination of trace amounts of chromium in tissues. …
Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia
…, A van Breda, MJ Sheridan, KM Sterling… - Journal of Vascular and …, 2014 - Elsevier
Purpose To report early findings from a prospective United States clinical trial to evaluate the
efficacy and safety of prostatic artery embolization (PAE) for benign prostatic hyperplasia (…
efficacy and safety of prostatic artery embolization (PAE) for benign prostatic hyperplasia (…
Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience
…, R Raabe, K Hagspiel, JF Benenati, K Sterling… - Journal of Vascular and …, 2008 - Elsevier
PURPOSE: To evaluate the success of lysis and clinical outcomes in patients treated with
ultrasound (US)–accelerated thrombolysis for deep vein thrombosis (DVT). MATERIALS AND …
ultrasound (US)–accelerated thrombolysis for deep vein thrombosis (DVT). MATERIALS AND …